COMMUNIQUÉS West-GlobeNewswire

Rule 2.9 Announcement
23/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 23 November 2018 [...]
Curetis Announces Financial Results for the First Nine Months of 2018
23/11/2018
Curetis Announces Financial Results for the First Nine Months of 2018 - Total year-on-year revenue growth of 43% globally, 207% in EMEA direct selling markets - Initial traction in U.S. market after Unyvero launch - [...]
Novartis announces landmark EU approval for one-time gene therapy Luxturna® to restore vision in people with rare inherited retinal disease
23/11/2018
Luxturna* (voretigene neparvovec) is the first gene therapy to treat an inherited retinal disease, indicated for children and adults with vision loss caused by mutations in both copies of the RPE65 gene and sufficient [...]
European Commission Approves Spark Therapeutics’ LUXTURNA® (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations
23/11/2018
LUXTURNA is first gene therapy for a genetic disease approved in both the U.S. and EU LUXTURNA is first and only gene therapy approved in EU for patients with an inherited retinal disease (IRD) Spark Therapeutics will [...]
Curetis Accelerates 510(k) Submission Preparation for Unyvero LRT in BAL Specimen Based on Positive FDA Feedback
23/11/2018
Curetis Accelerates 510(k) Submission Preparation for Unyvero LRT in BAL Specimen Based on Positive FDA Feedback U.S. FDA and Curetis agree on 510(k) requirements for clearing BAL as additional sample type for Unyvero [...]
Sensorion Enters Into Exclusive Negotiations with Pasteur Institute for Hearing Loss Gene Therapy Programs
23/11/2018
MONTPELLIER, France, Nov. 23, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN / PEA-PME eligible) announced today that it has entered into a letter of intent with Pasteur Institute (Paris, France) to [...]
Nova Leap Health Corp. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
23/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a [...]
North Bud Farms Provides Corporate Update
22/11/2018
TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- North Bud Farms Inc. (CSE: NBUD) ("NORTHBUD" or the "Company") is pleased to provide shareholders with an update on our corporate activities. Construction of our Cannabis [...]
Agility Health Announces Demand by Lender and Notice of Intention to Enforce Security
22/11/2018
HAMILTON, Ontario, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“Agility Health” or “Corporation”), a provider of orthotics, prosthetics and foot care services in Canada, today reported that its [...]
Canadian company proves exercise is a miracle drug
22/11/2018
Gym members see significant reductions in blood pressure, weight within 6 months of joining powerful exercise and healthy lifestyle coaching program VANCOUVER, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- For the [...]
Oral semaglutide demonstrates greater reductions in both HbA1c and body weight compared to Victoza® in Japanese people with type 2 diabetes
22/11/2018
Bagsværd, Denmark, 22 November 2018 - Novo Nordisk today announced the headline results from PIONEER 9, a 52-week trial with oral semaglutide vs Victoza ® (0.9 mg liraglutide) and vs placebo, all as monotherapy, in [...]
Canopy Rivers Secures International Joint Venture Rights and Accelerates Development at PharmHouse
22/11/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRES TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (“ Canopy Rivers ” or the “ Company ”) (TSXV: RIV) is pleased to announce it has, [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Nine Months Ended September 30, 2018
22/11/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Nov. 22, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Canada House Grants Common Shares to Senior Executive Management
22/11/2018
TORONTO, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) is pleased to announce the immediate granting of 4,300,000 stock options to senior employees at an [...]
Emerald Health Therapeutics Appoints Agro-Biotech President
22/11/2018
Thierry Schmidt brings extensive marketing and business strategy experience from consumer goods industry VICTORIA, British Columbia, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: [...]
Emerald Health Therapeutics nomme le président d’Agro-Biotech
22/11/2018
Thierry Schmidt apporte une vaste expérience en marketing et en stratégie commerciale provenant du secteur des biens de consommation VICTORIA, Colombie-Britannique, 22 nov. 2018 (GLOBE NEWSWIRE) -- Emerald Health [...]
Tetra Bio-Pharma Seeks Solutions for Second Hand Smoke From Cannabis
22/11/2018
ORLEANS, Ontario, Nov. 22, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to update the market on its [...]
The Management Board of JSC Olainfarm: shareholders chose stability and development by their voting
22/11/2018
Commenting on the decisions adopted by today's Extraordinary Shareholders' General Meeting of JSC Olainfarm, the Management Board of the company appreciates the voting of shareholders to leave the existing Articles of [...]
Oasmia Pharmaceutical Receives Approval from European Commission for Apealea® (paclitaxel micellar) in the European Union
22/11/2018
Apealea is approved in the European Union for treatment of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer in combination with carboplatin in first relapse Uppsala, [...]

Pages